Levetiracetam Safer Than Phenobarbital for Newborn Seizures
⚠️ Infant dosing/safety: medication and diet decisions for infants require individualized medical guidance.
Source: Clinical neurology and neurosurgery
Summary
Researchers studied the effectiveness and safety of two medications, levetiracetam (LEV) and phenobarbital (PB), for treating seizures in newborns. They looked at various studies published up until October 2023, focusing on how well these medications worked and any side effects they caused. A total of 15 studies were included in their analysis, which consisted of both randomized control trials and cohort studies.
The key findings showed that both LEV and PB were similarly effective in controlling neonatal seizures, meaning they worked about the same in stopping the seizures. However, levetiracetam had fewer reported side effects compared to phenobarbital. The most common side effects for both medications included low blood pressure and breathing problems, but sedation was only noted with levetiracetam in one study.
This research is important because it helps doctors and caregivers understand the safety and effectiveness of these two treatments for newborns with seizures. While both medications are effective, the lower risk of side effects with levetiracetam makes it a potentially better option for some infants. However, it's important to note that the studies reviewed had limitations, and more research may be needed to confirm these findings and explore long-term effects.
Free: Seizure First Aid Quick Guide (PDF)
Plus one plain-language weekly digest of new epilepsy research.
Unsubscribe anytime. No medical advice.
